darbepoietin alfa
- Generic Name
- darbepoietin alfa
The Effect of Roxadustat on Renal Oxygenation in Diabetes Nephropathy
Phase 2
Not yet recruiting
- Conditions
- Diabetes ComplicationsDiabetes; Nephropathy (Manifestation)
- Interventions
- First Posted Date
- 2023-04-12
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Region Stockholm
- Target Recruit Count
- 30
- Registration Number
- NCT05810311
- Locations
- 🇸🇪
Centre for diabetes, Stockholm, Sweden
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath